| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.06 |